Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT)

$311,500U10FY2016NSNIH

University Of Cincinnati, Cincinnati OH

Investigators

Linked publications & trials

Paper 37295955 Paper 36951450 Paper 34251039 Paper 31177973 Paper 30707228 Paper 30075875 Paper 30033056 Paper 29727818 Paper 27406108 Paper 26511448 Paper 26470777 Paper 26463690 Paper 26311751 Paper 26130090 Paper 26111891 Paper 25968935 Paper 25862116 Paper 25775975 Paper 25316275 Paper 24851800 Paper 24656865 Paper 24571111 Paper 24183923 Paper 24119622 Paper 24021679 Paper 24008570 Paper 23719147 Paper 23362085 Paper 23321443 Paper 23229778 Paper 23167925 Paper 23167847 Paper 22875082 Paper 22851473 Paper 22292566 Paper 22003912 Paper 22003910 Paper 20839239 Paper 20825807 Paper 20200383 Paper 19122033 Paper 17903930 Paper 17903881 Paper 17903815 Paper 17901378 Paper 17290088 Paper 16636234 Paper 16557295 Paper 16269646 Paper 16100021 Paper 15978311 Paper 15790947 Paper 15731465 Paper 15710849 Paper 15692114 Paper 15677792 Paper 15668451 Paper 15582155 Paper 15562430 Paper 15546262 Paper 15526968 Paper 15351343 Paper 15283708 Paper 15155974 Paper 15155969 Paper 15111660 Paper 15111659 Paper 15101822 Paper 15101821 Paper 15087556 Paper 14763951 Paper 14757893 Paper 14739423 Paper 14636322 Paper 14580658 Paper 12915341 Paper 12694680 Paper 12609154 Paper 12525235 Paper 12084862 Paper 12027913 Paper 11988610 Paper 11988589 Paper 11952083 Paper 11918470 Paper 11918463 Paper 11918458 Paper 11879369 Paper 11718497 Paper 11546899 Paper 11387488 Paper 11218052 Paper 11147566 Paper 11092609 Paper 11092608 Paper 11062274 Paper 11060540 Paper 10881246 Paper 10774633 Paper 10768309

Abstract

DESCRIPTION (provided by applicant): CinciNEXT is a unique collaboration between the free-standing Cincinnati Children's Hospital Medical Center (CCHMC) and the University of Cincinnati (UC) that aims to be a clinical site in the NlNDS-funded Network for Excellence in Neuroscience Clinical Trials (NEXT) network. The objective of the proposed application is to obtain infrastructural support to facilitate the implementation and optimize the quality of clinica trials conducted at the CinciNEXT site for the NEXT Network. Specific goals of CinciNEXT are to streamline startup, enhance recruitment, maximize retention and optimize study conduct of NEXT Network studies. Another goal is to actively contribute to the overall success of the NEXT network by participating in network governance, working groups (e.g. focused on planning and implementation of protocols), and network activities. The third goal is to implement ongoing training of new/junior clinical investigators/study coordinators to help them develop skills and experience to participate and/or lead future NEXT and other NINDS trials. These goals will be achieved by the combination of our experienced CinciNEXT leadership team (two co-Pls and two full-time research study coordinators), enthusiastic research collaborators, existing outstanding research infrastructure (including a CTSA), robust breadth and depth of patients available to participate in trials, and two supportive research administrations. Both institutions have shown their commitment to the NEXT Network by agreeing to use a standardized Master Trial Agreement, employ a Tier 1 level of centralized IRB review, and provide additional institutional funds to support two full-time CinciNEXT study coordinators (one pediatric-focused and one adult-focused). The CinciNEXT clinical site anticipates providing outstanding recruitment, retention and quality for NEXT Network trials, and thereby advancing treatments for neurological disorders. CinciNEXT proposes to be a key partner in this NINDS network that will provide a robust, standardized, and accessible infrastructure to facilitate rapid development and implementation of protocols in neurological disorders affecting adult and pediatric populations.

View original record on NIH RePORTER →